Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ventrus Phase 3 trial of Diltiazem showed no significant difference to placebo
Ventrus Phase 3 trial of Diltiazem showed no significant difference to placebo
Ventrus Phase 3 trial of Diltiazem showed no significant difference to placebo
Submitted by
admin
on February 12, 2014 - 9:17am
Source:
Yahoo/Fly on the Wall
News Tags:
Ventrus Biosciences
Diltiazem
VEN 307
Headline:
Ventrus Phase 3 trial of Diltiazem showed no significant difference to placebo
Do Not Allow Advertisers to Use My Personal information
